| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75359fc8b77543c76a591a83b1a6c5e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 |
| filingDate |
2021-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d255858f544cf48134657a052e02007 |
| publicationDate |
2021-09-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021194959-A1 |
| titleOfInvention |
Treatment of eye disorders with uridine phosphate derivatives |
| abstract |
The present invention relates to the treatment of eye disorders with P 2 Y receptor modulating compounds, and in particular to the treatment of eye disorders such as retinal neurodegenerations, including glaucoma, age-related macular degeneration and traumatic retinal injury, posterior and anterior uveitis of the eye, and dry eye with P 2 Y 6 receptor modulating compounds such as uridine phosphate derivatives and prodrugs. |
| priorityDate |
2020-03-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |